Agreed to some extent but the reverse acquisition of a public company with all kinds of baggage in a different market was not exactly the norm for a cannabis play. It is clear that management used the public status to offload as many convertibles as possible. The involvement with Auctus continues today and is toxic so the only guarantee is that ownership will continue to be diluted. I also question the efficacy of the delivery system licensing deal. Why would the licensor give Gpft an exclusive on anything until they prove they can sell? I’m not seeing it!
News 
Market Data 
Discover 
AI
